🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2, multicenter, single-arm study with a safety lead-in to i...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05195632
Treatments Being Tested
This phase Ib trial studies the side effects of pembrolizumab and trametini...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-06-26
Trial ID
NCT03299088
Treatments Being Tested
This phase II trial studies how well dabrafenib, trametinib, and spartalizu...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-01-29
Trial ID
NCT04310397
Treatments Being Tested
This aim of study to assess the safety and tolerability of SHR7390 and to d...
Status
Unknown
Location
The Cancer Center,Sun Yat-sen University
Start Date
2016-11
Trial ID
NCT02968485
Treatments Being Tested
This is a 2-part Phase 1b study of BGB-283 (lifirafenib) and PD-0325901 (mi...
Status
Completed
Location
University of California Los Angeles
Start Date
2019-05-01
Trial ID
NCT03905148
Treatments Being Tested
This is a single arm phase II trial focused on how dabrafenib and trametini...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2014-10-22
Trial ID
NCT02231775
Treatments Being Tested
This study is a Phase 1 dose-escalation open-label study to determine the r...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-04
Trial ID
NCT01138085
Treatments Being Tested
This is a two-part trial. "Solid tumor" in this protocol means solid tumor ...
Status
Terminated
Location
Please contact
Start Date
2012-09-30
Trial ID
NCT01668017
Treatments Being Tested
MEK is a critical member of the MAPK pathway involved in growth and surviva...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2005-11
Trial ID
NCT00174369
Treatments Being Tested
This phase II open label study will evaluate adolescents (≥ 16 years of age...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-06
Trial ID
NCT02096471
Treatments Being Tested